Document is current

Any future updates will be listed below

Correction: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients

Crossref DOI link: https://doi.org/10.1007/s00403-025-04136-8

Published Online: 2025-03-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark